Given that the pathological phenotypes of Aβ deposition and the phosphorylation of tau are hallmarks in AD, in order to confirm the Andro-interfered impairment of tau hyperphosphorylation in Aβ1–42-stimulated PC12 cells, the levels of phospho-tau and tau were checked. The gene discussed is MAPT; the disease is Alzheimer disease.